BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11896610)

  • 1. Feline STK gene expression in mammary carcinomas.
    De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
    Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Short Form of RON/STK in Feline Mammary Carcinoma.
    Maniscalco L; Guil-Luna S; Iussich S; Gattino F; Trupia C; Millan Y; de Las Mulas JM; Cespedez RS; Saeki K; Accornero P; De Maria R
    Vet Pathol; 2019 Mar; 56(2):220-229. PubMed ID: 30558510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variation and mRNA expression of the TWIST1 gene in cats with mammary hyperplasia and neoplasia.
    Baptista CS; Santos S; Laso A; Bastos E; Avila S; Guedes-Pinto H; Gärtner F; Gut IG; Castrillo JL; Chaves R
    Vet J; 2012 Feb; 191(2):203-7. PubMed ID: 21330172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
    De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF
    Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the cyclin A gene in canine and feline mammary tumors.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):783-7. PubMed ID: 10945302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.
    Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE
    Cancer Res; 2006 Dec; 66(24):11967-74. PubMed ID: 17178895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the mouse Ron/Stk receptor tyrosine kinase gene.
    Waltz SE; Toms CL; McDowell SA; Clay LA; Muraoka RS; Air EL; Sun WY; Thomas MB; Degen SJ
    Oncogene; 1998 Jan; 16(1):27-42. PubMed ID: 9467940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic variation in six cases of feline mammary tumours.
    Mayr B; Jugl M; Brem G; Reifinger M; Loupal G
    Zentralbl Veterinarmed A; 1999 Aug; 46(6):367-77. PubMed ID: 10481616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of the tumor suppressor gene brca2 in the cat.
    Oonuma T; Morimatsu M; Ochiai K; Syuto B
    J Vet Med Sci; 2003 Oct; 65(10):1123-6. PubMed ID: 14600353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
    Chen YQ; Zhou YQ; Angeloni D; Kurtz AL; Qiang XZ; Wang MH
    Exp Cell Res; 2000 Nov; 261(1):229-38. PubMed ID: 11082293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.
    Ordás J; Millán Y; Dios R; Reymundo C; de Las Mulas JM
    BMC Cancer; 2007 Sep; 7():179. PubMed ID: 17880730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
    Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
    Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.
    Sayasith K; Sirois J; Doré M
    Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2.
    Miller AD; Van Hoeven NS; Liu SL
    BMC Cancer; 2004 Sep; 4():64. PubMed ID: 15363108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma.
    Tanabe S; Nakadai T; Furuoka H; Oomachi T; Kobayashi Y; Omata Y; Koyama T; Hondo E; Uzuka Y; Sarashina T; Ducusin RJ; Shida T; Dorf ME
    Vet Rec; 2002 Dec; 151(24):729-33. PubMed ID: 12509077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are complex carcinoma of the feline mammary gland and other invasive mammary carcinoma identical tumours? Comparison of clinicopathologic features, DNA ploidy and follow up.
    Seixas F; Palmeira C; Pires MA; Lopes C
    Res Vet Sci; 2008 Jun; 84(3):428-33. PubMed ID: 17663997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.
    Persons DA; Paulson RF; Loyd MR; Herley MT; Bodner SM; Bernstein A; Correll PH; Ney PA
    Nat Genet; 1999 Oct; 23(2):159-65. PubMed ID: 10508511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.
    Zhou YQ; He C; Chen YQ; Wang D; Wang MH
    Oncogene; 2003 Jan; 22(2):186-97. PubMed ID: 12527888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
    Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
    Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.